Citation

Burger MT, Pecchi S, Wagman A, Ni ZJ, Knapp M, Hendrickson T, Atallah G, Pfister K, Zhang Y, Bartulis S, Frazier K, Ng S, Smith A, Verhagen J, Haznedar J, Huh K, Iwanowicz E, Xin X, Menezes D, Merritt H, Lee I, Wiesmann M, Kaufman S, Crawford K, Chin M, Bussiere D, Shoemaker K, Zaror I, Maira SM, Voliva CF.: Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer. ACS Med Chem Lett, Volume 2 (10), 2011

Authors

Atallah G, Bartulis S, Burger MT, Bussiere D, Chin M, Crawford K, Frazier K, Haznedar J, Hendrickson T, Huh K, Iwanowicz E, Kaufman S, Knapp M, Lee I, Maira SM, Menezes D, Merritt H, Ng S, Ni ZJ, Pecchi S, Pfister K, Shoemaker K, Smith A, Verhagen J, Voliva CF., Wagman A, Wiesmann M, Xin X, Zaror I, Zhang Y

Journal

ACS Med Chem Lett

Year

2011

DOI

10.1021/ml200156t

PubMed

24900266

Machine-readable

REST APIRDF